Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
about
Treatment approaches and adherence to urate-lowering therapy for patients with gout.Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.A cross-sectional internet-based patient survey of the management strategies for gout.Utility of the Morisky Medication Adherence Scale in gout: a prospective study.Factors influencing medication adherence in patients with gout: A descriptive correlational study.The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.Gout Self-Management in African-American Veterans: A Qualitative Exploration of Challenges and Solutions from Patients' Perspectives.Gout and comorbidity: a nominal group study of people with gout.Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China.Gout: cartoonized and bagatellized and still left untreated. Time to change.Education and non-pharmacological approaches for gout.Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.How Can We Improve Disease Education in People with Gout?Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.How patients with gout become engaged in disease management: a constructivist grounded theory study.Improving adherence to gout therapy: an expert review.
P2860
Q33597442-30BC1C6B-23A2-4B15-A3F7-07925B41C14BQ33797383-474E13E6-0EE1-4D65-B901-36C1C242BEEEQ35941652-BE720187-9FF2-4196-96CA-15E4FAB8DB40Q37485303-49681633-63DC-4FFC-BA0D-21B909EB4DDCQ38670679-CF8771E8-E212-44B5-9B4D-8FDBBE682115Q38759840-F8E3E631-32E3-4DE7-80EA-8D5ACA9FC762Q39018459-4EAA6D28-A779-40C3-B8AE-9289744F2335Q40366290-DB6757C5-3469-4586-8308-AA06BDC3C29AQ41711313-FD944FD0-D90C-4F9B-9171-BBBA0EAA4D8EQ42731691-EB4AA0E1-2C4B-4F28-A656-A4AC2B4C0646Q48036417-21383A02-34BD-4994-A448-0F4C0B4A8213Q49616112-9420EB31-23E2-4377-A79C-0A2518030557Q50075562-E67FFE19-A87D-4EC5-803B-B8E72623DF47Q52593279-C7F7EBB2-C13B-493E-B59E-078E5593ABFDQ52667810-B652CD0B-3437-49FC-A790-F758C14BD5B6Q53676007-FF5B4016-7EE7-4ACD-8B36-5FDE4A56CC96Q54961730-73E32C3C-CB3E-4AAD-B0A8-38EA10086952Q55220842-12899DFD-8377-49A3-80CF-12044CD21F65
P2860
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Facilitators and barriers to a ...... with gout: a qualitative study
@ast
Facilitators and barriers to a ...... with gout: a qualitative study
@en
type
label
Facilitators and barriers to a ...... with gout: a qualitative study
@ast
Facilitators and barriers to a ...... with gout: a qualitative study
@en
prefLabel
Facilitators and barriers to a ...... with gout: a qualitative study
@ast
Facilitators and barriers to a ...... with gout: a qualitative study
@en
P2860
P356
P1476
Facilitators and barriers to a ...... with gout: a qualitative study
@en
P2860
P2888
P356
10.1186/AR4524
P577
2014-03-29T00:00:00Z
P5875
P6179
1008405950